Recent Articles from Benzinga
Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.
Website: https://www.benzinga.com
Bitcoin (CRYPTO: BTC) miner MARA Holdings Inc (NASDAQ:MARA) reported second-quarter financial results after the market close on Tuesday.
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Strategy completes $2.52B IPO, purchases 21,021 BTC at $117,256/BTC. STRC stock begins trading July 30, netting $2.474B.
Via Benzinga · July 29, 2025
Starbucks reports third-quarter financial results after the market close on Tuesday. Here's a look at the key details from the report.
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Whirlpool are trading lower Tuesday after the company reported disappointing second-quarter earnings and significantly lowered its guidance for the full year.
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Shares of Deckers may be about to reverse and head higher. They have dropped to a price that has been a support level.
Via Benzinga · July 29, 2025
Tesla shares are trading marginally lower Tuesday afternoon. Investors continue to weigh the company's long-term artificial intelligence ambitions.
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Trump's tariffs are narrowing the U.S. trade gap faster than expected, fueling a potential second-quarter GDP bounce.
Via Benzinga · July 29, 2025
While Procter & Gamble posted strong fiscal Q4 earnings results, PG stock dipped on tariff concerns. Still, this could be a contrarian trade.
Via Benzinga · July 29, 2025
Meta Platforms has been spending aggressively on AI growth and personnel. Analysts said this is among the top key items to watch in Q2 results and guidance.
Via Benzinga · July 29, 2025
Here are five finance firms with high Benzinga Edge Value scores that also offer steady dividend yields. Let's take a look.
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Cryptocurrency markets are trading sideways one day ahead of the Federal Reserve’s decision on interest rates.
Via Benzinga · July 29, 2025
Shares of ScanTech AI Systems Inc. (NASDAQ: STAI) are trading higher Tuesday after the company announced a strategic partnership that could significantly boost its public sector reach.
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
CyberArk Software Inc. (NASDAQ: CYBR) shares are trading higher Tuesday after a report from The Wall Street Journal revealed that Palo Alto Networks is in talks to acquire the company for more than $20 billion.
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Shares of Super Micro Computer are trading marginally lower Tuesday. The market is anticipating the company's Q4 earnings report.
Via Benzinga · July 29, 2025
Nvidia CEO Jensen Huang once celebrated a company milestone with a tattoo. Investors who bought the stock after the tattoo image surfaced have been pleasantly rewarded.
Via Benzinga · July 29, 2025
Teva anticipates EBITDA recovery post-2025 as Austedo and Uzedy grow and generic Revlimid faces rising competition.
Via Benzinga · July 29, 2025
Universal Health Services beat Q2 earnings and raised full-year guidance, but growth concerns in behavioral health weighed on the core performance.
Via Benzinga · July 29, 2025
Tapestry slips as BofA downgrades on margin concerns and tempered FY26 growth outlook, despite continued strength at Coach.
Via Benzinga · July 29, 2025
Bausch Health will acquire DURECT and larsucosterol, aiming for FDA approval of a first treatment for alcoholic hepatitis via Phase 3 trials.
Via Benzinga · July 29, 2025
American Tower slips as steady Q2 results and 2025 guidance spark a cautious, wait-and-see investor stance.
Via Benzinga · July 29, 2025